(Finance) – TP ICAP Midcap increased the target price (to 19.9 euros per share from 19.1 euros, potential upside of 96%) and confirmed the recommendation (Buy) on the title GPIa company listed on Euronext Milan and active in the field of information systems and healthcare services, after the presentation of the new industrial plan to 2029.
Analysts have revised estimates upwards due to improved profitability driven by better mix and growth in the most profitable division (software). 2025 EPS revised from 0.78 to 0.90 euros per share, 2026 EPS from 0.89 to 1.17 euros per share.